General Hospital "G.Papanikolaou"; Pulmonogy Clinic
About General Hospital "G.Papanikolaou"; Pulmonogy Clinic
"ΓΕΝΙΚΟ ΝΟΣΟΚΟΜΕΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at General Hospital "G.Papanikolaou"; Pulmonogy Clinic
During the past decade, General Hospital "G.Papanikolaou"; Pulmonogy Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
2011-06-01
2018-04-10
Completed
797
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
2017-02-03
2019-12-26
Completed
326
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
2016-09-15
2021-08-01
Terminated
243
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
2018-06-27
2022-10-13
Terminated
76
A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004)
2021-05-12
2027-11-30
Recruiting
700
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
2021-12-01
2026-12-31
Recruiting
200
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
2021-12-29
2025-09-09
Recruiting
150
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at General Hospital "G.Papanikolaou"; Pulmonogy Clinic
According to Clinical.Site data, the most researched conditions in "General Hospital "G.Papanikolaou"; Pulmonogy Clinic" are
"Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "General Hospital "G.Papanikolaou"; Pulmonogy Clinic" in a lesser frequency.
Clinical Trials Intervention Types at General Hospital "G.Papanikolaou"; Pulmonogy Clinic
Most popular intervention types in "General Hospital "G.Papanikolaou"; Pulmonogy Clinic" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Tiragolumab" (2 trials), "Carboplatin" (1 trials), "Durvalumab" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at General Hospital "G.Papanikolaou"; Pulmonogy Clinic
The vast majority of trials in "General Hospital "G.Papanikolaou"; Pulmonogy Clinic" are
3 trials for "All" genders.
Clinical Trials Status at General Hospital "G.Papanikolaou"; Pulmonogy Clinic
Currently, there are NaN active trials in "General Hospital "G.Papanikolaou"; Pulmonogy Clinic".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in General Hospital "G.Papanikolaou"; Pulmonogy Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital "G.Papanikolaou"; Pulmonogy Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".